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In vitro susceptibility testing of Trichosporon asahii (13 strains)
and T. inkin (13 strains) against cyclic imides (succinimides,
naphtalimides and maleimides) in concentrations of 200 to
6,25 μg/mL was performed according to the diffusion agar method.
By the results obtained, the antifungal activity of the cyclic imides:
3,4-dichloro-N-phenyl-maleimide; 3,4-dichloro-N-phenyl-ethyl-
maleimide and 3,4-dichloro-N-phenyl-propyl-maleimide (50 μg/
mL) over T. asahii and T. inkin was important and it may be helpful
in showing perspectives in a search for new antimicotic products.
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A taxonomic revision proposed by Guého et al.
(1992) showed that the genus Trichosporon consists of six
human pathogenic species: T. asahii, T. inkin, T. mucoides,
T. cutaneum, T. asteroides and T. ovoides. These species
are causative agents of mucous-associated, systemic
mycosis, and superficial infection, including white piedra
(Guého et al., 1994; Therizol-Ferley et al., 1994; Pontes et
al., 2002a, b, c; Jahagirdir et al., 2002).
In therapeutics, the amphotericin B is not consistently
active over the Trichosporon species. The fluconazole seems
to be more effective and the use of a combined therapy has
been recommended due to the variable activity of the
amphotericin B and also due to its nefrotoxic effects (Walsh
et al., 1990; Anaissie et al., 1992). The great concern is
about the synthetic compounds, specially those analogs or
those which are originated from secondary metabolites
isolated from plants.
Calixto et al. (1984) could isolate an alkaloid of
leaves from Phyllanthus sellowianus (Euphorbiaceae) and
Tempesta et al. (1988) discovered the structure and named
it phyllanthimide. It has been used as a model to the
synthesis of analog compounds just like the cyclic imides.
Some these compounds presented are biological active
(Andricopulo et al., 1996; Correa et al., 1997; Cruz et al.,
1996; Aquino et al. 2003). For the reasons showed above,
some new alternatives to diagnose and treat infections
caused by the Trichosporon species are necessary. The
objective of this study was to evaluate the profile of




A total of ten synthetic analogs were selected, cyclic
imides, natural phyllanthimide alkaloid derivatives isolated
from P. sellowianus (Euphorbiaceae). The cyclic imides:
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two naphtalimides, three succinimides and five maleimides
(Figure 1) were synthesized in the Núcleo de Investigação
Químico-Farmacêutica (NIQFAR) from the Universidade
do Vale do Itajaí, Santa Catarina – SC, Brazil (Cechinel
Filho et al., 2003).
Each cyclic imide was diluted using
dimethylsulfoxide (DMSO) (0,3 mL) and sterile distilled
water (q.s.q. 3 mL). The final concentration of the solutions
ranged from of 200 to 6,25 µg/mL (Cleeland; Squires,
1991; Dantas et al., 2000; Belém, 2002).
Microorganisms
A total of twenty six human pathogenic
Trichosporon strains were used in the study: 13 strains of
T. asahii and 13 of T. inkin. Reference isolates were T.
asahii CBS 2479 and T. inkin CBS 5585 which were also
quality control isolates. All other strains were obtained
from clinical material (skin, nails, blood, and hair) from
patients suffering from deep and superficial infections and
from colonization.
FIGURE 1 - Imides cyclic: maleimides, succinimides and naftalimides.
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The present protocol was evaluated and approved
with no ethical restrictions by the Ethics Committee of the
Centro de Ciências da Saúde from the Universidade Fede-
ral da Paraíba (UFPB).
The mycological study was carried out at the Labo-
ratório de Micologia of the Departamento de Ciências Far-
macêuticas and the Trichosporon species were identified
according to morphology analysis, followed by physiologic
and biochemical profiles (Guého et al., 1992; Guého et al.,
1998).
Inoculum
The inoculum was prepared by subculture each
isolate in Sabouraud dextrose agar® (ASD) (DIFCO,
Detroit, U.S.A) at 28-30° C for 48 hours before the
experiment. The inoculum suspension was prepared by
picking colonies and suspending them in saline sterile
solution (0,85 %). The cell density of the suspension was
adjusted to 2.5 x 106 UFC/mL.
Microbiological assays
In vitro susceptibility testing of Trichosporon species
against cyclic imides was performed according to the
diffusion agar method (Bauer et al., 1966; Dantas et al.,
2000; Belém, 2002). In sterile Petri plates (90 X 15 mm),
as added 20 mL of ASD previously fused and cooled in 45
to 50 °C and to each strain 1 mL of the inoculum previously
prepared. After homogenization and solidification, some
cavities were made by using sterile glass cannulas (6 mm
of diameter). Aliquots of 50 µL of the cyclic imides
solutions and of ketoconazole (200 µg/mL) control drug
(Jansen Pharmaceutica, Titutsvile, NJ, U.S.A) was
dispensed into each cavity, followed by incubation at
28-30 °C for 48 h.
The criteria used for the definition of susceptibility to
cyclic imides was the presence of an inhibition zone with a
diameter bigger or equal to 10 mm around the cavity.
The strains were considered resistant when this
inhibition zone was less than 10 mm of diameter.
Inoculum was removed and subcultured 28-30 °C
for 48 h to check viability and purity on SDA plates.
Possible interference of DMSO over the growth of the
strains were evaluated adding an aliquot (50 µL) of
solvent. Absence of interference was considered when
there was not any inhibition zone around the cavity. Each
experiment was performed in triplicate, independently.
The susceptibility was determined by an arithmetic mean
from the inhibition zone halos obtained in the
experiments.
RESULTS AND DISCUSSION
The profile of susceptibility of the T. asahii and T.
inkin strains against ten cyclic imides in concentrations of
200 to 6,25 µg/mL were diversified. All the strains were
resistant to two succinimides (MA - 01 and MA - 03) and
to one naphtalimide (R - 82) in all concentrations tested
with an inhibition zone halo inferior to 10 mm diameter.
The susceptibility of the twenty six Trichosporon spp.
strains against seven cyclic imides (five maleimides, one
succinimide and one naphtalimide) was observed in
concentrations of 200 at 25 µg/mL (Tables I and II).
 Cyclic imides are organic compounds formed by the
group CO-N(R)-CO- being R a hydrogen atom from the
group alquila or arila. Maleimides, succinimides,
naphtalimides, citraconimides and derivatives, are
examples of cyclic imides subclasses (Cechinel Filho et al.,
1995; Andricopulo et al., 1998; Corrêa et al., 1997).
Lately, these compounds have called the attention of the
scientific community mainly, due to their therapeutic
potentialities as antispasmodics (Cechinel Filho et al.,
1995), analgesics (Andricopulo et al., 1998; Corrêa et al.,
1997), antibacterial (Cruz et al., 1996) and antifungal
(Dantas et al., 2000; Belém, 2002; Aquino et al., 2003).
The sensibility of the T. asahii and T. inkin strains against
the cyclic imides groups, especially to maleimides, is an
important event to notice.
Cechinel Filho et al. (1994) informed that in general,
maleimides derivatives show an activity which is
approximately 30 times higher than the succinimides
against Escherichia coli and Staphylococcus aureus,
suggesting that the double bond of the imido ring is a very
important fact related to this activity.
Cremlyn and Nunes (1987) have also demonstrated
that the sulphonyl-maleimides were much more active than
the sulphonyl-succinimides against Aspergillus niger, A.
glauco, Fusarium culmorum and Trichoderma viride
fungi. In this study, 92 % of the T. asahii strains and 77 %
of the T. inkin strains were inhibited by 3,4-dichloro-N-
benzyl-maleimide (A - 04) in a concentration of 25 and
50 µg/mL respectively. Therefore the compounds of 3,4-
dichloro-phenyl-maleimide (A – 28) and 3,4-dichloro-N-
phenyl-ethyl-maleimide (A – 02) and 3,4-dichloro-N-
phenyl-propyl-maleimide (A – 27) in a concentration of
50 µg/mL have inhibited the growth of 100 % of the T.
asahii strains and 92 % of the T. inkin strains. T. asahii
strains (54%) presented resistance to maleimides A - 04, A
- 02, A - 28 and A-26. These results were compatible with
those observed by Dantas et al. (2000). According to him,
the maleimides which presented higher activity against
Candida albicans strains were 3,4 dichloro-N-benzyl-
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maleimide and 3,4-dichloro-N-phenyl-propil-maleimide in
a concentration of 100 µg/mL; with the exception of 3,4-
dichloro-N-phenyl-ethyl-maleimide which did not inhibited
the growth of new strains of C. albicans, two of C.
guillermondii, one of C. krusei, three of C. parapsilosis,
two of C. stellatoidea and two of C. tropicalis.
According to structure of the maleimides, the
distance between the imido ring and the aromatic ring by
the introduction of different substitute groups may be an
important factor in relation to the activity of these
compounds against the researched species. Lima et al.
(1999) suggested that the distance between the imido ring
and the aromatic ring of the N-phenyl-alquil-3,4-dichloro-
maleimide influenced the antifungal action, that is, it was
more effective especially against Rhodotorula rubra and
Cryptococcus neoformans in a concentration of 50 µg/mL.
They also observed that the introduction of two chlorine
atoms in the imido ring did not affect the antifungal
activity. Cruz et al. (1996) also suggested that this was an
important factor in the antibacterial activity of N-aryl-
TABLE I – Profile of susceptibility in vitro T. asahii strains against cyclic imides
 T. asahii strains
Cyclic Concentration CBSb 36 129 130 152 162 168 293 781 856 912 1096 5010
imidesa less (µg/mL) 2479
Inhibition zone diameter (mm)
A-04 50 11 10 10 10 12 11 0 10 11 12 10 11 10
A-02 50 15 14 12 13 15 13 0 12 10 15 15 10 13
A-28 50 11 10 10 10 11 11 0 10 10 10 10 10 10
A-27 50 10 10 0 10 12 12 0 12 10 10 11 11 11
MA-2 100 11 0 10 10 12 0 0 0 0 11 0 10 10
A-26 200 0 11 0 0 12 0 0 14 14 15 0 11 11
R-85 200 15 0 0 0 11 0 17 0 0 18 0 10 11
Control drug c 200 18 18 15 16 18 15 10 20 17 18 18 14 18
a A-04: 3,4-dichloro-N-benzyl-maleimide; A-02: 3,4-dichloro-N-phenyl-ethyl-maleimide; A-28: 3,4-dichloro-N-phenyl-maleimide;
A-27: 3,4-dichloro-N-phenyl-propyl-maleimide; MA-2: N-phenyl-2a,6a,-dichlorobicyclo-[2.2.1]-hepta-4-eno-[5,6-C]-succinimide;
A-26: 3,4-dichloro-N-phenyl-butyl-maleimide; R-85: N-phenyl-naphtalimide. b CBS: Centraalbureau voor Schimmelcultures,
Baarn,
The Netherlands. c Control drug: Ketoconazole (200 µg/mL).
TABLE II – Profile of susceptibility in vitro T. inkin strains against cyclic imides
 T. inkin strains
Cyclic Concentration CBSb 21 39 40 66 148 155 397 618 775 1001 1095 2726
imides a less (µg/mL) 5585
Inhibition zone diameter (mm)
A-4 25 13 14 13 13 11 13 10 12 0 0 0 10 11
A-2 50 12 10 12 11 10 11 12 17 12 11 10 10 10
A-28 50 13 12 12 12 11 12 10 14 10 11 10 10 10
A-27 50 12 12 12 14 12 13 13 14 10 10 10 10 10
MA-2 100 11 12 0 10 0 10 0 12 10 0 10 0 0
A-26 100 11 11 11 11 10 11 0 11 10 0 10 11 0
R-85 200 16 13 12 0 0 11 0 20 12 0 12 14 0
Controlle drug b 200 21 20 21 21 18 19 20 22 18 21 16 21 18
a A-04: 3,4-dichloro-N-benzyl-maleimide; A-02: 3,4-dichloro-N-phenyl-ethyl-maleimide; A-28: 3,4-dichloro-N-phenyl-maleimide;
A-27: 3,4-dichloro-N-phenyl-propyl-maleimide; MA-2: N-phenyl-2a,6a,-dichlorobicyclo-[2.2.1]-hepta-4-eno-[5,6-C]-succinimide;
A-26: 3,4-dichloro-N-phenyl-butyl-maleimide; R-85: N-phenyl-naphtalimide. b CBS: Centraalbureau voor Schimmelcultures,
Baarn, The Netherlands. c Control drug: Ketoconazole (200 µg/mL).
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dichloromaleimide and N-aryl-naphtalimide against
Salmonella typhimurium, E. coli and S. aureus.
Corrêa et al. (1998), searching about a possible
mechanism of action of the cyclic imides, observed that
they did not have any effect against Neurospora crassa,
suggesting that they did not act by inhibiting a biosynthesis.
Therefore, the cyclic imides tested by them were active
against Trichophyton rubrum, T. mentagrophytes and
Microsporum canis. Further studies about the mechanism
of action of these cyclic imides will be very interesting to
check if such compounds, for example, act at the level of
the ergosterol biosynthesis.
The profile of susceptibility in vitro of the
Trichosporon species studied against the succinimides and
napthalimides derivatives decreased when compared to the
maleimidics. The least concentrations of N-phenyl-2a,6a-
dichlorobicyclo-[2.2.1]-hepto-4-eno-[5,6-C]-succinimide
(MA -02) and N-phenyl-naphtalmide (R – 85) were of 100
and 200 µg/mL respectively. Belém (2002) observed that
these two named compounds were also active but in lower
concentrations respectively 50 and 100 µg/mL against 90%
of the M. furfur strains. Dantas et al. (2000) observed that
species of Candida were resistant to such compounds in
concentrations of 6.25 and 200 µg/mL. This behavior may
be possibly related to the lack of a double bond present in
the imido ring, in the maleimides which produced the
inhibition of growth of microorganisms (Cruz et al., 1996;
Lima et al., 1999).
It was interesting to observe that the structure of the
phyllanthimide, an active naturally occurring alkaloid
which follows the recommendations of the folk medicine,
was used as model to the synthesis of compounds,
particularly to 3,4-dichloro-N-phenyl-maleimide, 3,4-
dichloro-N-phenyl-ethyl-maleimide and 3,4-dichloro-N-
phenyl-propyl-maleimide that presented activity in a
concentration of 50 µg/mL against the strains of T. asahii
and T. inkin. The perspectives in the search for natural and/
or synthetic products which can be used in the production
of antimicotics can be broadened.
RESUMO
Perfil de sensibilidade in vitro de cepas de
Trichosporon asahii e Trichosporon inkin frente a
imidas cíclicas
O perfil de sensibilidade in vitro de Trichosporon asahii
(13 cepas) e T. inkin (13 cepas) frente a imidas cíclicas
(naftalimidas, succinimidas e maleimidas) nas concentra-
ções de 6,25 a 200 µg/mL foi realizado pelo método de
difusão em agar. Pelos resultados obtidos, a atividade
antifúngica das imidas cíclicas: 3,4-dicloro-N-fenil-
maleimida; 3,4-dicloro-N-fenil-etil-maleimida e 3,4-
dicloro-N-fenil-propil-maleimida (50 µg/mL) sobre T.
asahii e T. inkin foi importante e pode abrir perspectivas
na busca de novos produtos antimicóticos.
UNITERMOS: Antifúngicos. Trichosporon asahii.
Trichosporon inkin. Ímidas cíclicas.
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